COMP <GO>
BKD vs LLY // EV/EBITDA & P/E VALUATION
Brookdale Senior Living Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: BKD 1
— LLY 11
▲ EV/EBITDA & P/E VALUATION LEADER: BKD
LAST: $10.27 (+2.91%) • MKT CAP: $2.45B
valuation
34.6x
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
valuation
36.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BKD VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BKD | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.20% | 83.64% | -57.44 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.30% | 32.36% | -32.06 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 34.6x | 36.4x | -1.82 | BKD | /valuation <GO> |
| Free Cash Flow Yield | 0.67% | 2.30% | -1.63 | LLY | /fcf-yield <GO> |
| Operating Margin | 0.40% | 40.21% | -39.81 | LLY | /operating-margins <GO> |
| Net Profit Margin | -8.20% | 31.90% | -40.10 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 45.51% | -43.31 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 9.29 | -9.09 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 9/9 | -5.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 66.6 | -20.60 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 30.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.45B | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BKD REV | LLY REV | BKD GROSS % | LLY GROSS % | BKD FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.19B | $65.18B | 26.2% | 83.0% | $16.5M | $16.81B |
| FY 2024 | $3.13B | $45.04B | 25.6% | 81.3% | -$35.1M | $8.82B |
| FY 2023 | $3.02B | $34.12B | — | 79.3% | $162.9M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BKD // BETA —
LLY // BETA 0.51